Alterity Therapeutics Limited (ATHE)
NASDAQ·Healthcare·Biotechnology
$5.09
+9.46%
Mkt Cap $32.18M
No analyst coverage available
We don't have analyst ratings or price target data for Alterity Therapeutics Limited yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.